Randeep Guleria

Indian pulmonologist

Randeep Guleria ▸ Facts ▸ Comments ▸ News ▸ Videos

Randeep Guleria is an Indian pulmonologist and the current director of the All India Institute of Medical Sciences, credited with the establishment of India's first centre for pulmonary medicines and sleep disorders at AIIMS. He was honoured by the Government of India in 2015 with Padma Shri, the fourth highest Indian civilian award. He is an alumnus of St. Columba's School, Delhi.

0 shares	Share Tweet Save Post Send



‘3 CT scans = Hiroshima bomb radiation’: Top doctor warns of overuse amid Covid AIIMS director Dr Randeep Guleria had warned against CT scans in mild Covid cases linking its radiation to cancer risk. Backing Dr Guleria, Dr Naval Vikram, Dept of Medicine, AIIMS, New Delhi and Dr.. Credit: HT Digital Content Duration: 06:28Published 6 days ago

Randeep Guleria discourages steroids & CT scans for mild cases \| Oneindia News AIIMs director Randeep Guleria has noted that mild covid cases in patients are turning into severe pneumonia because of strong medicaton and repeated tests. Guleria, who is a member of the National.. Credit: Oneindia Duration: 01:43Published 1 week ago

'1 CT scan = 300 X rays': AIIMS chief warns of cancer risk, overuse amid Covid AIIMS director Dr Randeep Guleria warned against CT scans in mild Covid cases. Guleria linked CT scan radiation to cancer risk. Guleria at a press conference said that CT scans and biomarkers are being.. Credit: HT Digital Content Duration: 02:31Published 1 week ago

No advantage of CT-Scan against mild COVID symptoms: Randeep Guleria While addressing a press conference in national capital over current situation of COVID-19 pandemic in the country, Delhi AIIMS Director Dr. Randeep Guleria on May 03 said there is no advantage of.. Credit: ANI Duration: 01:47Published 1 week ago

Take both doses even if you recovered from COVID: AIIMS Director Delhi AIIMS Director Dr Randeep Guleria on May 03 said, "The current recommendation is that, if you have recovered from COVID then you should take both doses of vaccine. In scientific language, the.. Credit: ANI Duration: 01:49Published 1 week ago

Covid-19: When should home isolation ideally end? Top doctor explains AIIMS Director Dr. Randeep Guleria explained when a person can end home isolation. Dr. Guleria said it is important to understand whwn to end home isolation in mild or asymptomatic cases. The pandemic.. Credit: HT Digital Content Duration: 03:08Published 2 weeks ago

COVID-19: AIIMS Director tells people when to discontinue home isolation During a press conference in Delhi over COVID situation in India, AIIMS Delhi Director Dr Randeep Guleria on April 30 advised people on when to discontinue home isolation. "When to discontinue home.. Credit: ANI Duration: 01:24Published 2 weeks ago

Remdesivir must be given only in hospitals by medical professionals: AIIMS Director Amid increasing demand for Remdesivir injections across the country in wake of the devastating second wave of COVID-19, Delhi AIIMS Director Dr Randeep Guleria on April 30 advised people not to take.. Credit: ANI Duration: 01:30Published 2 weeks ago

'There is unnecessary panic', says AIIMS Director amid COVID mess The devastating second wave of COVID-19 pandemic witnessed people rushing to hospital in large numbers, causing collapse of the health infrastructure in several states of the country, and saw severe.. Credit: ANI Duration: 01:40Published 2 weeks ago

3 held for selling Remdesivir injection at Rs 70, 000 Three people were arrested in Delhi for allegedly black marketing Remdesivir, an anti-viral drug used to treat COVID-19 infection. The accused were allegedly selling Remdesivir at Rs 70,000 per piece... Credit: ANI Duration: 01:06Published 2 weeks ago

'Don't panic': Top doctors on oxygen use, Remdesivir and when to visit hospital Top doctors addressed the nation on Covid-19 second surge. Doctors advised citizens to not panic. “No need to panic and hoard oxygen or Remdesivir,” said Dr. Randeep Guleria of AIIMS Delhi. “Only.. Credit: HT Digital Content Duration: 16:22Published 2 weeks ago

Remdesivir not a magic bullet: AIIMS Director Amid the shortage of anti-viral drug Remdesivir in the country in wake of devastating COVID-19 situation, AIIMS (All India Institute of Medical Sciences) Director Randeep Guleria said Remdesivir is not.. Credit: ANI Duration: 01:56Published 2 weeks ago

Don't panic in home isolation, by rushing to hospital, you're creating more chaos: AIIMS Director Amid increasing demand of Remdesivir injections across the country, Delhi AIIMS Director Dr Randeep Guleria on April 21 advised countrymen don't consider Remdesivir as a magic bullet as it requires for.. Credit: ANI Duration: 02:48Published 3 weeks ago

Vaccine prevents from getting disease in severe illness form, may not prevent infection: AIIMS Director As the vaccination drive against COVID-19 is underway across the country, Delhi AIIMS Director Dr Randeep Guleria on April 21 said, "The vaccine prevents you from getting the disease in the form of.. Credit: ANI Duration: 01:29Published 3 weeks ago

No problem if O2 saturation is above 94%, call doctor if falls: Narayana Health Chairman Delhi AIIMS Director Dr Randeep Guleria, Chairman of Narayana Health, Dr Devi Shetty and Dr Naresh Trehan, Chairman, Medanta on April 21 addressed issues related to COVID-19 in the country. The.. Credit: ANI Duration: 01:31Published 3 weeks ago

You Might Like

Strict lockdown should be clamped in areas with Covid positivity rate of over 10%: AIIMS director A strict lockdown should be imposed in areas where the Covid-19 case positivity rate is over 10 per cent or the bed occupancy is above 60 per cent, AIIMS Director Dr Randeep Guleria said on Tuesday,.. IndiaTimes - Published 1 week ago
CT scans not needed in mild Covid-19 cases: AIIMS chief Cautioning that CT scans and biomarker tests were not needed in mild Covid cases, AIIMS director Dr Randeep Guleria said one CT was equivalent to 300-400 chest Xrays and could pose potential risk of.. IndiaTimes - Published 1 week ago
DNA Special: When should a person with COVID symptoms go for CT scan? AIIMS Director Randeep Guleria said one CT scan is equivalent to 300-400 chest X-rays and this increases the risk of having cancer in later life. DNA - Published 1 week ago

AIIMS chief Randeep Guleria warns against going for CT scan in mild Covid cases, says it may do more harm than good Stressing that there is no need for doing CT scans in mild Covid cases, AIIMS Director Dr Randeep Guleria at a press conference said that many people are opting for the test the moment they find out.. IndiaTimes - Published 1 week ago
Lockdown in India: Here's what AIIMS chief Dr Randeep Guleria said Aggressive containment or lockdown is the only key as no healthcare system in the world can manage this kind of load. DNA - Published 1 week ago
No serious side-effect attached to Covid-19 vaccines: DGHS He made this statement while addressing a joint conversation on issues related to the Covid-19 situation with Director of AIIMS (Delhi) Doctor Randeep Guleria, Professor and Head of Department of.. IndiaTimes - Published 2 weeks ago

DNA explainer: When and how much oxygen do you need in COVID-19? AIIMS Director Dr Randeep Guleria tells when a patient should take oxygen if he is infected from coronavirus. DNA - Published 3 weeks ago
Mini-lockdown needed to curb COVID-19 spread, says AIIMS Director Dr Randeep Guleria People need to maintain a distance of 6 feet even after getting inoculated with the COVID-19 vaccine and there is a growing need for containment zones DNA - Published on April 2, 2021
Situation grim, we’re staring at another full-blown crisis: Guleria The Covid-19 situation in India will turn into a full-blown crisis if strict adherence to Covid-appropriate behaviour isn’t ensured, Dr Randeep Guleria, the director of All India Institute of Medical.. IndiaTimes - Published on April 1, 2021
Vaccine drive to be widened, jab for 50+ in 3 months: AIIMS Delhi director Dr Randeep Guleria The second phase of the nationwide vaccination drive against Covid-19 could be expanded within the next three months to include people who are 50 years and above, national Covid task force member and.. IndiaTimes - Published on March 19, 2021

New Covid-19 strains not 'more infectious', need to aggressively monitor situation: AIIMS Director Randeep Guleria Guleria also said that there was a need to aggressively study the mutations of the Covid-19 virus. "Currently we have vaccines with efficacy of 70 per cent , 80 per cent, 90 per cent so even if there.. IndiaTimes - Published on February 24, 2021
Herd immunity difficult to achieve: AIIMS director Randeep Guleria IndiaTimes - Published on February 21, 2021
Covid-19 vaccine maybe available in open market by year end, says AIIMS director Coronavirus vaccines might be available in the open market by end of the year only when prime targeted people are covered and there is an equivalence of supply and demand, said Dr Randeep Guleria,.. IndiaTimes - Published on February 17, 2021	COVID-19: THIS man becomes first person in India to receive coronavirus vaccine A sanitation worker became the first person in India to receive COVID-19 vaccine jab at AIIMS, New Delhi. The worker identified as Manish Kumar received the vaccine in the presence of Union Health.. DNA - Published on January 16, 2021
From eligibility to side-effects, all your questions about COVID-19 vaccination answered Here are all the queries answered by All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria. DNA - Published on January 4, 2021	2 virus mutations per month, no need for alarm: Guleria Delhi AIIMS director Dr Randeep Guleria, said here on Friday that the coronavirus had undergone several mutations, an average of two per month, and that new strains should not warrant unnecessary.. IndiaTimes - Published on December 25, 2020
Hopeful India will get Covid-19 vaccine nod by Dec end or early Jan: AIIMS director Randeep Guleria IndiaTimes - Published on December 2, 2020	Covid-19: Centre rushes high-level teams to 4 states to strengthen surveillance, testing The Centre has rushed high-level teams to Haryana, Rajasthan, Gujarat and Manipur where they will visit districts reporting high number of Covid-19 cases and support the state's efforts towards.. IndiaTimes - Published on November 19, 2020
Is India heading towards another lockdown from December 1? PIB clarifies Recently, AIIMS Delhi director Randeep Guleria warned that the second wave of coronavirus in India has begun. People should not leave the house unless absolutely necessary, he said DNA - Published on November 12, 2020	Keeping Pfizer's Covid-19 vaccine at low temperatures will be challenging for India, others: AIIMS Director Dr Randeep Guleria, Director, All India Institute of Medical Sciences Delhi (AIIMS), Delhi on Wednesday said the results of Pfizer's Covid-19 vaccine phase III trials are very encouraging but.. IndiaTimes - Published on November 11, 2020
Disease burden might increase drastically if Covid-19 & air pollution get combined: AIIMS director Guleria IndiaTimes - Published on November 10, 2020	Common people have to wait till 2022 to get COVID-19 vaccine: AIIMS Director Dr Randeep Guleria Dr Guleria reiterated the importance of maintaining social distancing and wearing masks. "One person not taking the precautions can lead to a superspreading event," he said. DNA - Published on November 7, 2020
Weeks after discharge, Amit Shah re-admitted to AIIMS Shah is getting treatment under Dr Randeep Guleria, director of AIIMS and his condition is said to be stable. DNA - Published on September 13, 2020	Amit Shah re-admitted to AIIMS weeks after discharge, condition stable Shah is getting treatment under Dr Randeep Guleria, director of AIIMS and his condition is said to be stable. DNA - Published on September 13, 2020
Randeep Guleria-led AIIMS team likely to visit Medanta to oversee Amit Shah's Covid-19 treatment A team of doctors led by AIIMS Director Dr Randeep Guleria is likely to visit Medanta hospital in Gurugram, where Union home minister Amit Shah has been admitted for Covid-19 treatment, sources at.. IndiaTimes - Published on August 2, 2020	AIIMS director on Covid vaccine human trials, community spread: Key points The clinical trial of the indigenously developed Covid-19 vaccine candidate Covaxin will be conducted in three phases, AIIMS director Randeep Guleria told reporters on Monday. Guleria, addressing the.. IndiaTimes - Published on July 20, 2020
India vulnerable to second wave of coronavirus: AIIMS director AIIMS director Randeep Guleria said India is also vulnerable to second wave of coronavirus and people should continue to follow social distancing, wearing mask and other precautions, after cases begin.. IndiaTimes - Published on June 25, 2020	Managing hotspots is key to ‘blunted peak’: AIIMS director AIIMS director Dr Randeep Guleria said on Thursday that if the Covid-19 hotspots are managed properly, India may witness a ‘blunted peak’. “It means that we will not have huge spike as has been.. IndiaTimes - Published on May 7, 2020
Covid-19 likely to peak in India in June-July: AIIMS director As per the modeling data and the way India's Covid-19 cases are increasing, it is likely that peak can come in June and July, said AIIMS-Delhi Director Dr Randeep Guleria on Thursday. "But there are.. IndiaTimes - Published on May 7, 2020	Stigma attached to Covid can cause more deaths: AIIMS head Stigmatising of Covid-19 patients and their families is resulting in cases turning up late at hospitals, with heightened breathlessness, and this could mean increased morbidity and mortality, Dr.. IndiaTimes - Published on April 23, 2020
Stigma attached to COVID-19 stopping many people from coming forward to get tested and treated: AIIMS Director AIIMS Director Prof Randeep Guleria said the tendency to not come forward due to stigma is leading not only to huge mental agonies and problems but also higher morbidity and mortality. DNA - Published on April 23, 2020	Some community spread in hotspots: AIIMS chief There may be some community spread of Covid-19 in hotspots and these areas need to be monitored closely to prevent community transmission of the virus, AIIMS director Dr Randeep Guleria said on Monday... IndiaTimes - Published on April 6, 2020
CJI rules out complete shutdown of SC amid coronavirus threat Chief Justice of India S A Bobde on Sunday made it clear that there cannot be a "complete shutdown" of courts due the novel coronavirus pandemic. The CJI held a meeting with four apex court judges, bar.. IndiaTimes - Published on March 15, 2020

Randeep Guleria

Indian pulmonologist

Randeep Guleria ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Strict lockdown should be clamped in areas with Covid positivity rate of over 10%: AIIMS director

CT scans not needed in mild Covid-19 cases: AIIMS chief

DNA Special: When should a person with COVID symptoms go for CT scan?

AIIMS chief Randeep Guleria warns against going for CT scan in mild Covid cases, says it may do more harm than good

Lockdown in India: Here's what AIIMS chief Dr Randeep Guleria said

No serious side-effect attached to Covid-19 vaccines: DGHS

DNA explainer: When and how much oxygen do you need in COVID-19?

Mini-lockdown needed to curb COVID-19 spread, says AIIMS Director Dr Randeep Guleria

Situation grim, we’re staring at another full-blown crisis: Guleria

Vaccine drive to be widened, jab for 50+ in 3 months: AIIMS Delhi director Dr Randeep Guleria

New Covid-19 strains not 'more infectious', need to aggressively monitor situation: AIIMS Director Randeep Guleria

Herd immunity difficult to achieve: AIIMS director Randeep Guleria

Covid-19 vaccine maybe available in open market by year end, says AIIMS director

COVID-19: THIS man becomes first person in India to receive coronavirus vaccine

From eligibility to side-effects, all your questions about COVID-19 vaccination answered

2 virus mutations per month, no need for alarm: Guleria

Hopeful India will get Covid-19 vaccine nod by Dec end or early Jan: AIIMS director Randeep Guleria

Covid-19: Centre rushes high-level teams to 4 states to strengthen surveillance, testing

Is India heading towards another lockdown from December 1? PIB clarifies

Keeping Pfizer's Covid-19 vaccine at low temperatures will be challenging for India, others: AIIMS Director

Disease burden might increase drastically if Covid-19 & air pollution get combined: AIIMS director Guleria

Common people have to wait till 2022 to get COVID-19 vaccine: AIIMS Director Dr Randeep Guleria

Weeks after discharge, Amit Shah re-admitted to AIIMS

Amit Shah re-admitted to AIIMS weeks after discharge, condition stable

Randeep Guleria-led AIIMS team likely to visit Medanta to oversee Amit Shah's Covid-19 treatment

AIIMS director on Covid vaccine human trials, community spread: Key points

India vulnerable to second wave of coronavirus: AIIMS director

Managing hotspots is key to ‘blunted peak’: AIIMS director

Covid-19 likely to peak in India in June-July: AIIMS director

Stigma attached to Covid can cause more deaths: AIIMS head

Stigma attached to COVID-19 stopping many people from coming forward to get tested and treated: AIIMS Director

Some community spread in hotspots: AIIMS chief

CJI rules out complete shutdown of SC amid coronavirus threat